三伏贴市场乱象追踪：10万+销量仅为日用品，商家称“和医院差不多”，大夫反驳“纯属误导”

Core Viewpoint - The article highlights the misleading marketing practices surrounding "Sanfu Ties" (summer patches) sold online, which are often misrepresented as medical products despite being ordinary consumer goods [1][3][10]. Group 1: Misleading Marketing Practices - Many online sellers exaggerate the efficacy of Sanfu Ties, claiming they can treat various ailments, which is a common phenomenon in e-commerce [3][10]. - A specific product, "Ai Cao Sanfu Tie," sold on Taobao, has over 100,000 sales and claims to be suitable for both adults and children, yet it is classified as a consumer good and not a medical product [4][6]. - The product's packaging states it cannot replace medical devices or drugs, but sellers still imply it has similar effects to hospital-grade patches [4][6]. Group 2: Lack of Regulatory Standards - The standard Q/NJJJ016, under which many of these products are produced, is a corporate standard and not a national or industry standard, indicating lower quality control [8][10]. - The absence of clear national standards for these products allows for significant consumer confusion, as many do not understand the difference between corporate standards and medical regulations [10][15]. Group 3: Consumer Misunderstanding - Consumers often struggle to differentiate between various product classifications, such as "drug approval" and "medical device registration," leading to misconceptions about safety and efficacy [15]. - Many consumers mistakenly believe that any product with an execution standard is safe and effective, which has been exploited by sellers [15]. Group 4: Misuse of Traditional Medicine Concepts - Sellers misuse traditional Chinese medicine concepts, such as "winter disease summer treatment," to market their products, simplifying complex medical theories into misleading claims [10][12]. - The marketing often includes vague disclaimers about contraindications, leaving consumers unaware of potential risks associated with using these products [11][12]. Group 5: Regulatory Challenges - The regulatory environment for these products is weak, with oversight primarily focused on packaging and labeling rather than the actual efficacy or safety of the products [13][14]. - The online sales channels, such as Taobao and Douyin, present additional challenges for regulation, as many products are sold by individual sellers, complicating enforcement [13][14].